Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body

Annals of the New York Academy of Sciences
Patricia Iozzo

Abstract

Obesity is a phenotype resulting from a series of causative factors with a variable risk of complications. Etiologic diversity requires personalized prevention and treatment. Imaging procedures offer the potential to investigate the interplay between organs and pathways underlying energy intake and consumption in an integrated manner, and may open the perspective to classify and treat obesity according to causative mechanisms. This review illustrates the contribution provided by imaging studies to the understanding of human obesity, starting with the regulation of food intake and intestinal metabolism, followed by the role of adipose tissue in storing, releasing, and utilizing substrates, including the interconversion of white and brown fat, and concluding with the examination of imaging risk indicators related to complications, including type 2 diabetes, liver pathologies, cardiac and kidney diseases, and sleep disorders. The imaging modalities include (1) positron emission tomography to quantify organ-specific perfusion and substrate metabolism; (2) computed tomography to assess tissue density as an indicator of fat content and browning/ whitening; (3) ultrasounds to examine liver steatosis, stiffness, and inflammation; and (...Continue Reading

References

Dec 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R R Verani
Jun 1, 1992·The Journal of Clinical Investigation·P NuutilaU Wegelius
Mar 1, 1974·The Anatomical Record·R J Merklin
Aug 1, 1980·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J J BergeronB I Posner
Jan 1, 1981·European Journal of Applied Physiology and Occupational Physiology·P HuttunenV Kinnula
Jun 15, 1996·The Journal of Clinical Investigation·M RodenG I Shulman
Mar 12, 1999·Annual Review of Medicine·M Roden, G I Shulman
Nov 18, 2000·Eating and Weight Disorders : EWD·S Cinti
Feb 24, 2001·Lancet·G J WangJ S Fowler
Jul 18, 2001·Current Opinion in Clinical Nutrition and Metabolic Care·G Mithieux
Aug 6, 2002·The Journal of Clinical Endocrinology and Metabolism·Kirsi A VirtanenPirjo Nuutila
Sep 25, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Thomas F HanyGustav K von Schulthess
Feb 13, 2003·Obesity Research·Kirsti HällstenPirjo Nuutila
Mar 20, 2003·The Journal of Biological Chemistry·Joan TordjmanBénédicte Antoine
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Patricia IozzoPirjo Nuutila
May 15, 2003·American Journal of Respiratory and Critical Care Medicine·Richard J SchwabAllan I Pack
Jun 18, 2003·Circulation·Michaela Scheuermann-FreestoneKieran Clarke
Oct 29, 2003·Circulation·Tomasz MazurekYi Shi
Aug 11, 2004·The Journal of Biological Chemistry·Gilles MithieuxAmandine Gautier-Stein
Jan 4, 2005·NeuroImage·Paul A M SmeetsJeroen van der Grond
Mar 11, 2006·The Journal of Clinical Investigation·Alessandro PocaiLuciano Rossetti
Mar 21, 2006·NeuroImage·Nicola PannacciulliPietro A Tataranni
Aug 24, 2006·The Journal of Clinical Endocrinology and Metabolism·Mikko KankaanpääPatricia Iozzo
May 15, 2007·Journal of Nuclear Medicine Technology·Narendra NairRajnath Jaiswar
Jun 15, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hiroko IijimaShiro Maeyama

❮ Previous
Next ❯

Citations

Jul 5, 2016·Frontiers in Human Neuroscience·Justin W RiedererGuido K W Frank
Jul 22, 2016·Brain Sciences·Ruth FrancoClement Hamani
May 3, 2019·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Jonas SteinhauserSebastian Kozerke
Feb 6, 2018·Therapeutic Advances in Psychopharmacology·Darrin J LeeAndres M Lozano
Jul 25, 2019·European Journal of Nuclear Medicine and Molecular Imaging·Charles-Henri MalbertRichard L Young

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Asprosin

Asprosin is a fasting-induced hormone produced in the white adipose tissue to stimulate the hepatic release of glucose into the bloodstream. Discover the latest research on this protein hormone here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Related Papers

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Vanessa J LavallardPhilippe Gual
Nature Reviews. Drug Discovery
Sarah Crunkhorn
© 2021 Meta ULC. All rights reserved